PA
VRE

PharVision Advisers’s Veris Residential VRE Stock Holding History

PharVision Advisers’s Portfolio VRE Stock Details VRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,159
Closed -$300K – 640
2025
Q4 		$300K Sell
20,159
-6,365
-24% -$94K 0.15% 270
2025
Q3 		$403K Buy
+26,524
New +$394K 0.23% 79

Other funds holding VRE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
H2CM
H/2 Credit Manager Stamford, Connecticut $526M AUM 70.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PharVision Advisers's VRE Position: Q1 2026 in Review

PharVision Advisers sold out of Veris Residential (VRE) in Q1 2026, closing a stake of 20,159 shares — an estimated $300K sold.

PharVision Advisers first reported a position in VRE in Q3 2025 and held it in 2 quarters. The position peaked at $403K in Q3 2025. 237 funds tracked by Wall St. Rank hold VRE as of Q1 2026.

  • PharVision Advisers reported no remaining Veris Residential position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 20,159 Veris Residential shares in Q1 2026, an estimated $300K.
  • PharVision Advisers first reported a position in Veris Residential in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Veris Residential position peaked at $403K in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Veris Residential as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.